JAPAN MEDICINE REFERENCE

Dawa za Japani

Search Japanese product names, generics, brands, marketing authorization holders, strengths and PMDA primary sources. Prescription medicines are reference-only and are not sold online.

3 records

Filter by therapeutic area

Maeneo yote15 Moyo na mishipa4 Onkolojia4 Metaboli2 Neurolojia1 Imunolojia3 Mfumo wa hewa1

デュピクセント皮下注300mg／200mg ペン・シリンジ · 300 mg / 2 mL

Japanese product photo · 300 mg / 2 mL · Lyall0 / CC BY-SA 4.0

ImunolojiaRx

Dupixent

Dupilumab · デュピクセント皮下注300mg／200mg ペン・シリンジ

Main use

Used for selected inflammatory conditions such as atopic dermatitis and severe asthma, depending on formulation.

SC pen / syringe200 mg / 300 mgサノフィ株式会社

PMDAView full reference →

リンヴォック錠7.5mg／15mg／30mg／45mg・内用液0.1% · 7.5 mg / 15 mg

Japanese product photo · 7.5 mg / 15 mg · アッヴィ / 共同通信PRワイヤー

ImunolojiaRx

Rinvoq

Upadacitinib · リンヴォック錠7.5mg／15mg／30mg／45mg・内用液0.1%

Main use

Used for selected rheumatoid arthritis, atopic dermatitis and inflammatory bowel disease, depending on formulation.

tablet / oral solution7.5 mg / 15 mg / 30 mg / 45 mg; oral solution 0.1%アッヴィ合同会社

PMDAView full reference →

スキリージ皮下注55mg／75mg／150mg シリンジ・150mgペン · 150 mg / 1 mL pen

Japanese product photo · 150 mg / 1 mL pen · スキリージ.jp / アッヴィ

ImunolojiaRx

Skyrizi

Risankizumab · スキリージ皮下注55mg／75mg／150mg シリンジ・150mgペン

Main use

The subcutaneous products on this page are mainly used for plaque psoriasis and psoriatic arthritis.

SC syringe / pen55 mg / 75 mg / 150 mgアッヴィ合同会社

PMDAView full reference →

PMDAPrimary sources first

Approval status, labels, safety information and current revisions should be confirmed in official Japanese sources such as PMDA. TOKYO MEDI provides a reference index and verification context, not a replacement for official documents.

PMDA ↗